MTOR and age-related macular degeneration: Importantly, SkQ1 showed promise in rodent models of AMD by suppressing atrophic changes in RPE, regulating expression of αB-crystallin, decreasing the mTOR signaling and reducing the level of Aβ deposition, and blocking the development of the neurodegenerative processes associated with AMD [468-471].